BIOD Insider Trading Activity and SEC Form 4 Filings
BIOD insider trading summary
No open-market insider purchases or sales of Biodel Inc (BIOD) have been reported on SEC Form 4 in the past 12 months.
Latest BIOD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 20, 2013 | Brian JG Pereira | Director | Sell | $11K (4,734 @ $2.26) |
| Dec 20, 2013 | Ira Lieberman | Director | Buy | $25K (10,800 @ $2.29) |
| Dec 7, 2012 | Paul S Bavier | General Counsel/Corp. Sec. | Sell | $34K (12,256 @ $2.80) |
| Nov 2, 2012 | Paul S Bavier | General Counsel/Corp. Sec. | Sell | $3K (1,100 @ $2.78) |
| Nov 2, 2012 | Alan Seth Krasner | Chief Medical Officer | Sell | $3K (1,100 @ $2.78) |
| Nov 1, 2012 | Alan Seth Krasner | Chief Medical Officer | Sell | $7K (2,400 @ $2.82) |
| Nov 1, 2012 | Paul S Bavier | General Counsel/Corp. Sec. | Sell | $7K (2,400 @ $2.82) |
| Sep 20, 2012 | Errol B Desouza | CEO | Buy | $33K (10,000 @ $3.34) |
| Mar 13, 2012 | Paul S Bavier | General Counsel/Corp. Sec. | Sell | $5K (8,385 @ $0.59) |
| Dec 16, 2011 | Brian JG Pereira | Director | Sell | $10K (15,000 @ $0.65) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.